These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35704126)

  • 41. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
    Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM;
    PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil.
    Silva EM; Acosta AX; Santos EJ; Netto EM; Lemaire DC; Oliveira AS; Barbosa CM; Bendicho MT; Galvão-Castro B; Brites C
    Braz J Infect Dis; 2010; 14(5):468-75. PubMed ID: 21221475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No evidence of an association between transient HIV viremia ("Blips") and lower adherence to the antiretroviral medication regimen.
    Miller LG; Golin CE; Liu H; Hays RD; Hua J; Wenger NS; Kaplan AH
    J Infect Dis; 2004 Apr; 189(8):1487-96. PubMed ID: 15073687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.
    Wright ST; Hoy J; Mulhall B; Oʼconnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA
    J Acquir Immune Defic Syndr; 2014 May; 66(1):55-64. PubMed ID: 24463783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.
    Moraka NO; Moyo S; Mayondi G; Leidner J; Ibrahim M; Smith C; Weinberg A; Li S; Thami PK; Kammerer B; Ajibola G; Musonda R; Shapiro R; Gaseitsiwe S; Lockman S
    J Acquir Immune Defic Syndr; 2019 May; 81(1):118-124. PubMed ID: 30964806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon-inducible protein 10 (IP-10) is associated with viremia of early HIV-1 infection in Korean patients.
    Lee S; Chung YS; Yoon CH; Shin Y; Kim S; Choi BS; Kim SS
    J Med Virol; 2015 May; 87(5):782-9. PubMed ID: 25678246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytomegalovirus (CMV) Viremia in People With Human Immunodeficiency Virus (HIV): Should We Treat the CMV? or the HIV? or Both?
    Levi LI; Molina JM
    Clin Infect Dis; 2023 Mar; 76(6):975-976. PubMed ID: 36625163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C viral load and mother-to-child transmission: A systematic review and meta-analysis.
    Deng S; Zhong W; Chen W; Wang Z
    J Gastroenterol Hepatol; 2023 Feb; 38(2):177-186. PubMed ID: 36066543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of Detectable Viremia, Outcomes, and Implications for Management of People Living With HIV Who Are Receiving Antiretroviral Therapy in Southern Nigeria.
    Akpan UU; Nwanja EN; Badru T; Toyo OE; Idemudia AM; Sanwo O; Okeke PN; Gana B; Idem S; Idiong HM; Khamofu HG; Bateganya MH
    Open Forum Infect Dis; 2023 Dec; 10(12):ofad562. PubMed ID: 38088982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevalence and correlates of plasma cytomegalovirus viremia among newly reported HIV/AIDS patients in Taizhou city, 2017-2018].
    Qiao SJ; Zhou SJ; Xu LL; Chen XX; Xu YY; Shen WW; Liu X; Lin HJ; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):316-320. PubMed ID: 33626622
    [No Abstract]   [Full Text] [Related]  

  • 52. Association Between Cytomegalovirus and Epstein-Barr Virus Viremia And Human Immunodeficiency Virus DNA Levels in the Reservoir of Kenyan Infants Receiving Antiretroviral Therapy.
    Slyker JA; Guthrie B; Pankau M; Tapia K; Wamalwa D; Benki-Nugent S; Ngugi E; Huang ML; Njuguna I; Langat A; John-Stewart G; Lehman D
    J Infect Dis; 2021 Jun; 223(11):1923-1927. PubMed ID: 33064809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia.
    Trunfio M; Joseph SB; Ghisetti V; Romito A; Martini C; Cusato J; Audagnotto S; Pesci Kincer L; Ferrara M; Sala A; Imperiale D; Di Perri G; Calcagno A
    J Neurovirol; 2018 Feb; 24(1):132-136. PubMed ID: 29243133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.
    Cardozo EF; Luo R; Piovoso MJ; Zurakowski R
    J Theor Biol; 2014 Mar; 345():61-9. PubMed ID: 24378646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study.
    Moretti S; Alesse E; Di Marzio L; Zazzeroni F; Ruggeri B; Marcellini S; Famularo G; Steinberg SM; Boschini A; Cifone MG; De Simone C
    Blood; 1998 May; 91(10):3817-24. PubMed ID: 9573019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Social Vulnerability among Foreign-Born Pregnant Women and Maternal Virologic Control of HIV.
    Premkumar A; Yee LM; Benes L; Miller ES
    Am J Perinatol; 2021 Jul; 38(8):753-758. PubMed ID: 33368072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Tat immunity defines CD4
    Tripiciano A; Picconi O; Moretti S; Sgadari C; Cafaro A; Francavilla V; Arancio A; Paniccia G; Campagna M; Pavone-Cossut MR; Sighinolfi L; Latini A; Mercurio VS; Pietro MD; Castelli F; Saracino A; Mussini C; Perri GD; Galli M; Nozza S; Ensoli F; Monini P; Ensoli B
    EBioMedicine; 2021 Apr; 66():103306. PubMed ID: 33839064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
    Stapleton JT; Chaloner K; Zhang J; Klinzman D; Souza IE; Xiang J; Landay A; Fahey J; Pollard R; Mitsuyasu R
    AIDS; 2009 Mar; 23(5):605-10. PubMed ID: 19194270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Low-level Viremia on Treatment Outcomes During ART - Is it Time to Revise the Definition of Virological Failure?
    Poveda E; Crespo M
    AIDS Rev; 2018; 20(1):71-72. PubMed ID: 29628513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994-2012.
    Ocampo JM; Plankey M; Zou K; Collmann J; Wang C; Young MA; Liu C; Ripple JA; Kassaye S
    BMC Public Health; 2015 Dec; 15():1277. PubMed ID: 26695971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.